Remicade (infliximab) - J&J
Humira (adalimumab) - AbbVie
Stelara (ustekinumab) - J&J
Entyvio (vedolizumab) - Takeda
http://www.ncbi.nlm.nih.gov/pubmed/41388917
 
Christopher Roberts; Eathar Shakweh; Miles Parkes; Mohammed Sharip; Qian Zhang; Tariq Ahmad
 
Dec 13, 2025
 
Next